FDA Rx Compounding Policy Follows 1992 Compliance Guide
Executive Summary
FDA is returning to the drug compounding policy laid out in a 1992 compliance policy guide in response to a recent Supreme Court decision
You may also be interested in...
Pharmacy Compounding: Second Draft Of FDA Compliance Guide Coming Soon
FDA is likely to issue a second draft of its pharmacy compounding compliance policy guide before issuing a final policy
Pharmacy Compounding: Second Draft Of FDA Compliance Guide Coming Soon
FDA is likely to issue a second draft of its pharmacy compounding compliance policy guide before issuing a final policy
Supreme Court Reaffirms Least Restrictive Standard For Ad Controls
The Supreme Court decision overturning restrictions on advertising of compounded drugs suggests that any moves by Congress to control direct-to-consumer advertising will face a close, skeptical review in court